doxorubicin-14-O-hemiadipate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Previously, we have reported partial circumvention ofP-glycoprotein (Pgp)-associated resistance to doxorubicin(Dox) in MCF7/R… (More)
  • figure 1
Is this relevant?
1994
1994
Bleb fibrosis after glaucoma filtering surgery and proliferative vitreoretinopathy after retinal detachment surgery are… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
Is this relevant?
1990
1990
Adriamycin (ADR; doxorubicin) and its highly lipophilic, less toxic analogue N-benzyl-adriamycin-14-valerate (AD 198) were found… (More)
Is this relevant?
1989
1989
N-Trifluoroacetyladriamycin-14-O-hemiadipate (AD 143), a DNA nonbinding derivative of Adriamycin, was studied for its effect on… (More)
Is this relevant?
1987
1987
The N-acylanthracyclines AD32 (N-trifluoroacetyladriamycin-14-valerate) and AD143 (N-trifluoroacetyladriamycin-14-O-hemiadipate… (More)
Is this relevant?
1986
1986
N-Trifluoroacetyladriamycin-14-O-hemiadipate (AD 143) is the most active among the 14-O-hemiester adriamycin-trifluoroacetamide… (More)
Is this relevant?
1986
1986
The interaction of three second-generation anthracycline derivatives with polynucleotides, supercoiled DNA, and calf thymus… (More)
Is this relevant?
1986
1986
On the consideration that the highly active DNA-nonbinding adriamycin analogues N-(trifluoroacetyl)adriamycin 14-valerate and N… (More)
Is this relevant?
1985
1985
The effects of N-benzyladriamycin-14-valerate (AD198) and N,N-dimethyladriamycin-14-valerate (AD199), two novel lipophilic N… (More)
Is this relevant?
1984
1984
The effect of N-trifluoroacetyladriamycin-14-O-hemiadipate (AD 143), a new derivative of adriamycin, on various steps of the… (More)
Is this relevant?